Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs66977371 | chr6:131709250 | TA/T | 2.34E-5 | 176 | 24.85 | 27.27 | 17.4 | KM Plot |
PCPG | rs66982778 | chr16:1744736 | G/A | 0 | 175 | 25.6 | 18.75 | 2.93 | KM Plot |
PCPG | rs6708380 | chr2:24341312 | T/C | 0.000114 | 177 | 25.28 | 27.27 | 17.43 | KM Plot |
PCPG | rs6708688 | chr2:24356476 | C/T | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs6709140 | chr2:118553400 | T/A | 1.89E-5 | 176 | 25.17 | 25.97 | 11.65 | KM Plot |
PCPG | rs6709860 | chr2:242549624 | A/G | 4.95E-5 | 176 | 25.2 | 29.95 | 19.75 | KM Plot |
PCPG | rs67102443 | chr2:239084602 | A/G | 2.93E-5 | 177 | 33.32 | 20.2 | 19.28 | KM Plot |
PCPG | rs6710667 | chr2:24339554 | G/A | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs6711928 | chr2:191470188 | C/T | 0.000458 | 176 | 25.87 | 24.23 | 27.18 | KM Plot |
PCPG | rs67130283 | chr13:114167707 | CAG/C | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs6714449 | chr2:242547302 | G/A | 3.06E-5 | 176 | 25.87 | 26.62 | 20.28 | KM Plot |
PCPG | rs6714623 | chr2:24292735 | C/T | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs6714743 | chr2:24292813 | C/T | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs6714810 | chr2:242547542 | G/T | 2.99E-5 | 176 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs6716070 | chr2:136544651 | G/T | 2.26E-5 | 178 | 9.72 | 24.98 | 25.77 | KM Plot |